Featured
GLP-1 access expands with launch of oral Ozempic
Novo Nordisk is launching a pill form of Ozempic, offering a new option for type 2 diabetes and positioning pharmacies at the forefront of access, adherence, and the growing GLP-1 demand.
An Rx for affordable health care
The entire system would benefit from directing consumers to the lowest-cost point of care.
Make AI empowering, not domineering
AI is reshaping how consumers shop and how retailers compete. But as the technology grows more powerful, a critical question is emerging: How much AI is too much?
NACDS must face changing times
David Pinto looks at where NACDS needs to make some changes to meet its future destiny.
Harris Teeter expands GLP-1 access
Regional grocer integrates medications, dietitians and affordability tools to support weight management.
Kroger Health and Hy-Vee announce line up for 2026 Nourishing Change Conference
The conference is scheduled for June 2–4, 2026, at the Iowa Events Center in Des Moines.
FMI welcomes House passage of Farm Bill
“FMI looks forward to working with policymakers on both sides of the aisle to ensure final enactment of a Farm Bill that meets the needs of the entire food industry and the consumers we serve.”
Walmart deploying experts to elevate the in-store beauty experience
Associates in the role receive specialized training and are tasked with delivering a more consultative, service-driven experience in stores.
Kroger Health and Hy-Vee announce line up for 2026 Nourishing Change Conference
The conference is scheduled for June 2–4, 2026, at the Iowa Events Center in Des Moines.
Pure Leaf launches new ‘Mental Focus’ sparkling iced tea
Pure Leaf is teaming up with two-time Olympic gymnast Jordan Chiles and digital wellness tool Brick to highlight the importance of finding focus when it’s needed most.
GLP-1 access expands with launch of oral Ozempic
Novo Nordisk is launching a pill form of Ozempic, offering a new option for type 2 diabetes and positioning pharmacies at the forefront of access, adherence, and the growing GLP-1 demand.
GoodRx expands offerings to now include Ozempic Pill for Type 2 diabetes patients
Eligible self-pay patients can access the oral diabetes treatment for as low as $149 per month.